GT Biopharma, Inc.GTBPNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P14
Within normal range
vs 5Y Ago
-6x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -161.73% |
| 2024 | -73.25% |
| 2023 | 63.62% |
| 2022 | 64.00% |
| 2021 | -105.02% |
| 2020 | 26.78% |
| 2019 | 85.09% |
| 2018 | -79.78% |
| 2017 | -1575.96% |
| 2016 | 145.52% |